Abstract
Amphotericin B (AmB) traditionally has been the mainstay of therapy for children with candidemia but is associated with drug-related toxicities (DRT). Studies investigating the risk factors for AmB DRT in children are limited. A retrospective review of patients aged 6 months to ≤18 years with candidemia who received ≥1 dose of AmB from 2003 to 2009 was conducted at Texas Children's Hospital, Houston, TX. Patient demographics, risk factors, drug dosages, laboratory adverse effects and infusion-related side effects (INFRT) were recorded. A total of 223 episodes of candidemia occurred in 179 patients. AmB was administered in 172 (77%) episodes. Amphotericin B deoxycholate, Amphotericin B lipid complex and liposomal Amphotericin B were administered in 65 (38%), 96 (55%) and 11 (6.4%) episodes, respectively. When the first episode of AmB use was analyzed separately (n = 138), DRT occurred in 83% (n = 114); nephrotoxicity occurred in 45% (n = 62), hypokalemia in 47% (n = 62) and INFRT in 31 % (n = 41). The most common INFRT was chills and rigors (80%, n = 33) followed by fever (31.7%, n = 13) and hypotension (9.7%, n = 4). Patients with lower baseline creatinine clearance were at increased risk of having nephrotoxicity than those wit...Continue Reading
References
Nov 1, 1989·Antimicrobial Agents and Chemotherapy·J M Benson, M C Nahata
Sep 1, 1988·The Journal of Pediatrics·G KorenC Prober
Jun 1, 1987·Klinische Wochenschrift·R A BranchH Heidemann
Apr 1, 1987·The Journal of Infectious Diseases·J R StarkeS L Kaplan
Apr 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S D GoodwinT H Grasela
Oct 23, 1997·British Journal of Haematology·H G PrenticeB E Gibson
Mar 21, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A PathakL Carvalho
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M H WhiteC B Miller
Mar 11, 1999·The New England Journal of Medicine·T J WalshJ S Holcenberg
Apr 12, 2000·International Journal of Radiation Oncology, Biology, Physics·A TrottiW Curran
Jun 23, 2000·Journal of Pediatric Hematology/oncology·E S SandlerL Pietrelli
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R WingardUNKNOWN L Amph/ABLC Collaborative Study Group
Dec 6, 2000·Mycoses·I W Blau, A A Fauser
Mar 17, 2001·The Journal of Antimicrobial Chemotherapy·A D LuberB J Guglielmo
Sep 29, 2001·Kidney International·D W BatesR Platt
Nov 14, 2001·The American Journal of Medicine·S HarbarthM H Samore
May 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maureen M RodenThomas J Walsh
Jun 26, 2004·Journal of Pediatric Hematology/oncology·Ran D Goldman, Gideon Koren
Oct 2, 2004·The New England Journal of Medicine·Thomas J WalshBen E dePauw
Feb 11, 2005·The Pediatric Infectious Disease Journal·Joseph M WileyThomas J Walsh
Apr 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Barbara D Alexander, John R Wingard
Nov 9, 2006·The Annals of Pharmacotherapy·Douglas BurkeJohn R Foringer
May 26, 2007·Journal of Clinical Pharmacology·Ran D GoldmanGideon Koren
Sep 25, 2008·The Journal of Antimicrobial Chemotherapy·David L PatersonUNKNOWN PRoACT Investigators
May 1, 2010·The Pediatric Infectious Disease Journal·Johan A MaertensUNKNOWN Caspofungin Pediatric Study Group
Jul 2, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Michael ZappitelliStuart L Goldstein
Feb 18, 2011·Journal of Cancer·Asim Jamal ShaikhShiyam Kumar
Mar 30, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Cécile Courivaud, Didier Ducloux
Jul 21, 2011·Nephrology·Dan GaoZhang-Suo Liu